HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Hematologic Malignancies

Hematologic malignancies, which affect the blood, bone marrow, and lymphatic systems, include leukemia, lymphoma, and myeloma. These cancers often present with symptoms like fatigue, swollen lymph nodes, and unexplained weight loss, making early detection challenging. Research is heavily focused on identifying genetic mutations and alterations in the blood that can help in diagnosis, prognosis, and treatment. Advances in stem cell transplantation, CAR-T cell therapy, and novel drug therapies have revolutionized the treatment landscape. Ongoing clinical trials aim to refine these approaches, reduce relapse rates, and improve patient survival rates. Moreover, there is a growing focus on minimizing the long-term side effects of treatments, such as infertility and secondary cancers, which can significantly impact patients' lives.

Committee Members
Speaker at International Cancer Conference 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
ICC 2026 Speakers
Speaker at International Cancer Conference 2026 - Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Speaker at International Cancer Conference 2026 - Yi Chih Liang

Yi Chih Liang

National Sun Yat-Sen University, Taiwan
Speaker at International Cancer Conference 2026 - Omar Mohammad Alqaisi

Omar Mohammad Alqaisi

Al-Zaytoonah University, Jordan
Speaker at International Cancer Conference 2026 - Wu Junyao

Wu Junyao

Changhai Hospital, China
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp